article thumbnail

Heat-Related Mortality Trends Worsened from 1999 to 2023

HCPLive

Heat-related mortality rates in the US notably grew between 1999 and 2023, particularly since 2016.

105
105
article thumbnail

The FDA calls them 'recalls,' yet the targeted medical devices often remain in use

Medical Xpress - Cardiology

In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device—"a Class I recall, the most serious type," the FDA said.

91
article thumbnail

PO-06-028 SHORT-TERM OUTCOMES OF LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE 2016-2020

HeartRhythm

Since its first Food and Drug Administration (FDA) approval in 2016, there has been a significant uptrend in the utilization of leadless pacemakers (LL-PPM).

article thumbnail

Abstract 195: Changing Trends of Thrombolysis and Thrombectomy for Low Severity Stroke: National Inpatient Sample Analysis (2016?2020)

Stroke: Vascular and Interventional Neurology

1) This study aims to examine the evolving trends of intravenous thrombolysis (IVT), endovascular thrombectomy (EVT), and their combination in low NIHSS acute ischemic stroke (AIS) management in the United States from 2016 to 2020.MethodsWe MethodsWe accessed the national inpatient sample database from 2016 through 2020.

article thumbnail

Intensive Versus Traditional Cardiac Rehabilitation: Mortality and Cardiovascular Outcomes in a 2016–2020 Retrospective Medicare Cohort

Circulation: Cardiovascular Quality & Outcomes

Qualifying events were captured from May 1, 2016 to December 31, 2019 and ICR/CR utilization captured from May 1, 2016 to December 31, 2020. Dose-response was assessed by the number of days attended.Results:From 2016 to 2019, 1 277 358 unique patients met at least one qualifying indication for ICR/CR from 2016 to 2019.

article thumbnail

PO-03-166 CHARACTERISTICS AND 5-YEAR TREND IN LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE (2016-2020)

HeartRhythm

Leadless VVI pacemakers (LL-PPM), first approved by Food and Drug Administration (FDA) in 2016, emerged as an alternative for transvenous pacemakers to reduce device-related complications.

article thumbnail

Abstract WP235: Cannabis Use Disorder in Elderly Stroke Survivors (?65 Years) Elevates the Risk of Stroke Recurrence: An Analysis From the National Inpatient Sample (2016-2019)

Stroke Journal

From 2016 to 2019, CUD among stroke survivors rose from 0.24% to 0.37%. Multivariable statistical methods assessed demographics, comorbidities, and temporal trends.Results:Out of 5,284,119 elderly stroke survivors, 16,820 (0.3%) had CUD and presented younger (median age: 69 vs. 79), predominantly male (68.8% vs. 28.4%).